Eleftherios Phedias Diamandis (born October 8, 1952)[1] is a Greek Cypriot-Canadian biochemist who specializes in clinical chemistry.
He is also Division Head of Clinical Biochemistry at Mount Sinai Hospital and Biochemist-in-Chief at the University Health Network, both of which are also located in Toronto.
From the American Association for Clinical Chemistry, he has received the Morton K. Schwartz Award for Significant Contributions in Cancer Research Diagnostics, among other awards; he is also a member of the Association's Hall of Fame.
"[4][5] This insight from Diamandis triggered John Carreyrou to further investigate the claims that had been made by Theranos.
At the time, Theranos was widely considered a reliable and functional analysis company.